Basit öğe kaydını göster

dc.contributor.authorGumusel, F
dc.contributor.authorYalcintepe, Leman
dc.contributor.authorIssever, S
dc.contributor.authorTiryaki, D
dc.contributor.authorBermek, E
dc.contributor.authorKorkut, C
dc.contributor.authorKiremit-Korkut, N
dc.contributor.authorUzun-Altinoz, S
dc.date.accessioned2021-03-03T07:40:19Z
dc.date.available2021-03-03T07:40:19Z
dc.date.issued1998
dc.identifier.citationKorkut C., Yalcintepe L., Kiremit-Korkut N., Uzun-Altinoz S., Issever S., Gumusel F., Tiryaki D., Bermek E., "Serum proteins with NAD+ glycohydrolase activity and anti-CD38 reactivity--elevated levels in serum of tumour patients.", Cancer letters, cilt.126, sa.1, ss.105-9, 1998
dc.identifier.issn0304-3835
dc.identifier.othervv_1032021
dc.identifier.otherav_1338fa98-3807-4eae-ac2b-82cbdfb79920
dc.identifier.urihttp://hdl.handle.net/20.500.12627/18382
dc.identifier.urihttps://doi.org/10.1016/s0304-3835(97)00531-4
dc.description.abstractNAD(+) glycohydrolase activities in serum samples from cancer patients were two-to three-fold higher than the activities in samples from healthy controls. SDS-PAGE analysis of serum samples followed by Western blotting revealed the presence of two proteins of similar to 45 and similar to 21 kDa that were immunoreactive with human CD38-specific monoclonal antibodies T16, HIT2 and OKT10. These proteins appeared to be more abundant in serum from cancer patients. NAD(+) glycohydrolase activity in serum could be enriched by immunoaffinity chromatography by using T16-Sepharose 4B. The results suggest that the relative abundance of proteins immunologically related to CD38 may account for the elevated levels of glycohydrolase activities in serum of tumour patients. (C) 1998 Elsevier Science Ireland Ltd.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectİç Hastalıkları
dc.subjectONKOLOJİ
dc.subjectOnkoloji
dc.titleSerum proteins with NAD+ glycohydrolase activity and anti-CD38 reactivity--elevated levels in serum of tumour patients.
dc.typeMakale
dc.relation.journalCancer letters
dc.contributor.department, ,
dc.identifier.volume126
dc.identifier.issue1
dc.identifier.startpage105
dc.identifier.endpage9
dc.contributor.firstauthorID57459


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster